Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults
Recruitment status was Not yet recruiting
The purpose of this study is to determine whether astaxanthin (ASX) supplementation will reduce obesity-induced oxidative stress and improve lipid profile in overweight and obese adults.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
- Evaluation of the plasma MDA (malonaldehyde) level [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
MDA is a three chain aldehyde produced during the composition of a lipid hydroperoxide and is a well known indicator of lipid peroxidation.
The purpose of this stduy is to determine whether ASX supplementation lowers oxidative stress using MDA,a biomarker.
|Study Start Date:||August 2010|
|Estimated Study Completion Date:||March 2011|
|Estimated Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
Dietary Supplement: astaxanthin
Please refer to this study by its ClinicalTrials.gov identifier: NCT01167205
|Contact: Yeo-kyu Youn, Doctor||+82 2 2072 firstname.lastname@example.org|
|Korea, Republic of|
|Clinical Research Institute Seoul National University Hospital||Not yet recruiting|
|Seoul, Korea, Republic of, 110-744|
|Contact: Wan Gyoon Shin, Ph D, Pharm D +82 2 740 85556 email@example.com|